MUMBAI, India , Oct. 17, 2022 /PRNewswire/ — Ajanta Pharma, a specialty pharmaceutical formulation firm, has been awarded as “Best Managed Companies” in India by Deloitte for 2022.
The choice course of for the award had rigorous analysis of administration skills for Strategy; Capabilities and Innovation; Governance and Financials; Culture and Commitment. It as soon as once more confirms Ajanta’s agile administration, resilient technique and superior efficiency.
Mr. Yogesh Agrawal, Managing Director, Ajanta Pharma acquired the award on the Best Managed Companies programme held on 14 October at Deloitte Knowledge Center in Mumbai.
“We are delighted to receive the Best Managed Companies award from Deloitte as it validates our emphasis on commitment towards excellence in people, processes, infrastructure and practices. This award is dedicated to over 7,000 motivated Ajantaites spread globally who make Ajanta an exciting and vibrant place to work,” mentioned Mr. Yogesh Agrawal.
Ajanta Pharma is a specialty pharmaceutical formulation firm having branded generic business in India and 30 rising markets, generic business in US and establishment business in Africa. Ajanta is set to seek out solutions for patient-needs by creating differentiated 1st to market merchandise. This good product portfolio supplies the corporate management in varied molecule and therapeutic segments. Company’s floor presence in all of the rising markets supplies it an edge to construct enduring product manufacturers and robust fairness with clients. Moreover, the corporate’s strong provide chain ensures these medicines can be found for needy sufferers throughout the globe each single day.
Ajanta’s success in several markets is backed by its sturdy perception in R&D. Company’s R&D has sturdy capabilities in completed product improvement of various dosage varieties by designing strong formulation. Ajanta has been constantly creating troublesome and complicated merchandise to harness affected person wants. Company’s 800+ scientists embrace know-how to seek out applicable options to handle the challenges confronted by sufferers throughout the globe.
Company has 6 world class formulation & 1 API manufacturing services in India having best-in-class gear. These services are run by a talented and educated group who observe excellent high quality techniques to make sure world-class high quality merchandise. Stringent authorities just like the US FDA and WHO have permitted the corporate’s services at Paithan in Maharashtra and Dahej in Gujarat.
For final 10 monetary years, firm has posted wholesome efficiency with its Revenue from Operations rising at 15% CAGR and web revenue at 23% CAGR.
For extra particulars go to:
www.ajantapharma.com
For common updates observe us on twitter:
www.twitter.com/ajantapharmaltd
For particular queries, contact:
Abhineet Kumar Tel: +91 22 66061814 Email: [email protected]
Reuters: AJPH.NS, Bloomberg: AJP:IN, NSE: AJANTPHARM, BSE: 532331
Corporate Identity Number (CIN): L24230MH1979PLC022059
Safe Harbour Statement
Photo: https://mma.prnewswire.com/media/1922396/Yogesh_agrawal_MD_Ajanta_Pharma.jpg
